RecruitingDiabetic Peripheral Neuropathic Pain
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Eligible age
18–80 yrs
Accepts
All genders
Locations
31 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN).
Sponsor: Vertex Pharmaceuticals Incorporated
Where it's recruiting
Alabama
Anniston · Birmingham · Daphne
Arizona
Phoenix · Scottsdale
California
Fresno · Long Beach · Los Angeles · Pomona …
Colorado
Englewood
District of Columbia
Washington D.C.
Florida
DeLand · Doral · Fort Myers · Hallandale …
Georgia
Decatur
Idaho
Meridian
Illinois
Chicago · Flossmoor
Indiana
Evansville
Kansas
Wichita
Kentucky
Lexington
Source: ClinicalTrials.gov · NCT06628908 · last updated 2026-10-15